Altered 5-HT2A and 5-HT4 postsynaptic receptors and their intracellular signalling systems IP3 and cAmP in brains from depressed violent suicide victims

Neuropsychobiology

Volumn 49, Issue 4, 2004, Pages 189-195

  Rosel, Pilar ^a,d   Arranz, Belén ^b   Urretavizcaya, Mikel ^c   Oros, Miguel ^a   San, Luis ^b   Navarro, Miguel Angel ^a  

^a CSU de Bellvitge   (Spain)

^b HOSPITAL GENERAL DE GRANOLLERS   (Spain)

^c CSUB Hospital Princeps d'Espanya ^*  (Spain)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

5 HT2a receptors; 5 HT4 receptors; Human brain; Second messengers; Suicide

Indexed keywords

ANTIDEPRESSANT AGENT; CYCLIC AMP; INOSITOL 1,4,5 TRISPHOSPHATE; POSTSYNAPTIC RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 4 RECEPTOR; TRIPHOSPHOINOSITIDE;

ADOLESCENT; ADULT; AGED; AMYGDALOID NUCLEUS; ARTICLE; BINDING AFFINITY; BINDING SITE; BRAIN; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEPRESSION; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; PARAMETER; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SUICIDE; VICTIM; VIOLENCE;

ADOLESCENT; ADULT; AGED; BINDING SITES; BRAIN; CASE-CONTROL STUDIES; CYCLIC AMP; DEPRESSIVE DISORDER; FEMALE; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE; KETANSERIN; MALE; MIDDLE AGED; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN, 5-HT4; SIGNAL TRANSDUCTION; SUICIDE; TRITIUM;

EID: 2342527059     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077365     Document Type: Article

References (43)

1. Mann JJ: Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology 1999;21:99S-105S.
2. Mendelson SD: The current status of the platelet 5-HT2A receptor in depression. J Affect Disord 2000;57:13-24.
3. Van Heeringen C: Suicide, serotonin and the brain. Crisis 2001;22:66-70.
4. Mann JJ, McBride PA, Brown RP, Linnoila M, Leon AC, DeMeo MD, Mieczkowski TA, Myers JE, Stanley M: Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients. Arch Gen Psychiatry 1992;49:442-446.
5. Arranz B, Eriksson A, Mellerup E, Plenge P, Marcusson J: Brain 5-HT1A, 5-HT1D, 5-HT2 receptors in suicide victims. Biol Psychiatry 1994;35:457-463.
6. Lowther S, De Parmentier F, Crompton MR, Katona CLE, Horton RW: Brain 5-HT2 receptors in suicide victims: Violence of death depression and effects of antidepressant treatment. Brain Res 1994;642:281-289.
7. Pandey GN: Altered serotonin function in suicide. Evidence from platelet and neuroendocrine studies. Ann NY Acad Sci 1997;836:182-200.
8. Rao ML, Hawellek B, Papassotiropoulos A, Deister A, Frahnert C: Upregulation of the platelet serotonin 2A receptor and low blood serotonin in suicidal psychiatric patients. Neuropsychobiology 1998;38:84-89.
9. Dwivedi J, Pandey GN: Quantitation of 5-HT2A receptor mRNA in human postmortem brain using competitive RT-PCR. Neuroreport 1998;9:3761-3765.
10. Turecki G, Brière R, Dewar K, Antonetti T, Lesage AD, Seguin M, Chawky N, Vanier C, Alda M, Joober R, Benkelfat C, Rouleau GA: Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. Am J Psychiatry 1999;156:1456-1458.
11. Drevets WC: Neuroimaging studies of mood disorders. Biol Psychiatry 2000;48:813-829.
12. Drevets WC: Neuroimaging and neuropathological studies of depression: Implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol 2001;11:240-249.
13. Leonard BE: Peripheral markers of depression. Curr Opin Psychiatry 2000;13:61-68.
14. Leonard BE: Evidence for a biochemical lesion in depression. J Clin Psychiatry 2000;61:12-17.
15. Berridge JM, Irvine RF: Inositol phosphates and cell signalling. Nature 1989;341:197-205.
16. Berridge JM: Inositol trisphosphate and diacylglycerol as second messenger. Biochem J 1984;220:345-360.
17. Pandey SC, Davis JM, Schwertz DW, Pandey GN: Effect of antidepressant and neuroleptics on phosphoinositide metabolism in human platelets. J Phamacol Exp Ther 1991;256:1010-1018.
18. Pandey GN, Dwivedi Y, Pandey SC, Conley RR, Roberts RC, Tamminga CA: Protein kinase C in postmortem brain of teenage suicide subjects. Neurosci Lett 1997;228:111-114.
19. Warsh JJ, Li PP: Second messenger systems and mood disorders. Curr Opin Psychiatry 1996;9:23-29.
20. Mikuni M, Kusumi I, Kagaya A, Kuroda Y, Mori H, Takahashi K: Increased 5-HT2 receptor function as measured by serotonin stimulated phosphoinositide hydrolysis in platelets of depressed patients. Biol Psychiatry 1991;15:49-61.
21. Karage F, Bovier P, Rudolph W, Gaillard JM: Platelet phosphoinositide signaling system: An overstimulated pathway in depression. Biol Psychiatry 1996;39:697-702.
22. Pacheco MA, Jope RS: Phosphoinositide signalling in human brain. Prog Neurobiol 1996; 50:255-273.
23. Shimon H, Agam G, Belmaker RH, Hyde TM, Kleinman JE: Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder. Am J Psychiatry 1997;154:1148-1150.
24. Subhash MN, Jagadeesh S: Imipramine-induced changes in 5-HT2 receptor and inositoltrisphosphate levels in rat brain. Neurochem Res 1997;22:1095-1099.
25. 3H]cAMP binding sites are unaltered in depressed suicides, but decreased by antidepressants. Brain Res 1997;758:223-228.
26. Rosel P, Arranz B, Urretavizcaya M, Oros M, San L, Vallejo J, Navarro MA: Different distribution of the 5-HT reuptake complex and the postsynaptic 5-HT2A receptors in Brodmann areas and brain hemispheres. Psychiatry Res 2002;111:105-115.
27. 3 in human brain. Neurosci Res Comm 1999;24:107-115.
28. 3H] paroxetine binding sites in suicide brains. Psychiatry Res 1998;82:161-170.
29. Arranz B, Rosel P, San L, Sarró S, Navarro MA, Marcusson J: Characterization of the 5HT4 binding site in human brain. J Neural Transm 1998;105:575-586.
30. Markwell MA, Haas SM, Bieber LL, Tolbert NE: A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 1987;87:202-225.
31. Scatchard G: The attractions of proteins for small molecules and ions. Ann NY Acad Sci 1949;51:660-672.
32. Gross-Isseroff R, Biegon A, Voet H, Weizman A: The suicide brain: A review of postmortem receptor/transporter binding studies. Neurosci Biobehav Rev 1998;22:653-661.
33. Arranz B, Blennow K, Eriksson A, Mansson JE, Marcusson J: Serotonergic, noradrenergic and dopaminergic measures in suicide brains. Biol Psychiatry 1997;41:1000-1009.
34. Cheetham SC, Crompton MR, Katona CLE, Horton RW: Brain 5-HT2 receptor binding sites in depressed suicide victims. Brain Res 1998;443:272-280.
35. Shah PJ, Ebmeier KP, Glabus MF: Cortical gray matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study. Br J Psychiatry 1998;172:527-532.
36. Domenech T, Beleta J, Fernandez AG, Gristwood RW, Cruz Sanchez F, Tolosa E, Palacios JM: Identification and characterization of serotonin 5-HT4 receptor binding sites in human brain: Comparison with other mammalian species. Mol Brain Res 1994;21:176-180.
37. Grossman CJ, Kilpatrick GJ, Bunce KT: Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain. Br J Pharmacol 1993;109:618-624.
38. Eglen RM, Wong EHF, Dumuis A, Bockaert J: Central 5-HT4 receptors. Trends Pharmacol Sci 1995;16:391-397.
39. Cowburn RF, Marcusson JO, Eriksson A, Wiehager B, O'Neill C: Adenylyl cyclase activity and G-protein subunit levels in postmortem frontal cortex of suicide victims. Brain Res 1994;633:297-304.
40. Dowlatshahi D, MacQueen GM, Wang JF, Reiach JS, Young LT: G Protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: Effects of diagnosis, suicide and treatment at the time of death. J Neurochem 1999;73:1121-1126.
41. Rehavi M, Jerusalemi Z, Aviv A, Laor N, Podliszawski KL, Shavat S, Weizman R: Interaction between antidepressant and phosphoinositide signal transduction system in human platelets. Biol Psychiatry 1993;33:40-44.
42. 3H]inositol 1,4,5-trisphosphate binding sites and expressed inositol 1,4,5-trisphosphate receptor protein level in platelets of depressed patients. Psychopharmacology 1998;138:47-54.
43. Jakobs KA, Watanabe J, Bawer S: Interactions between the hormone-sensitive adenylate cyclase system and the phosphoinositide-metabolizing pathway in human platelets. J Cardiovasc Pharmacol 1986;8:61-64.